Switch to
More onapp

Procter & Gamble Health Ltd

PGHL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,794 cr, stock is ranked 453
Low RiskStock is 1.23x as volatile as Nifty
4,141.0047.80 (+1.17%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,794 cr, stock is ranked 453
Low RiskStock is 1.23x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
35.29
PB RatioPB Ratio
11.02
Dividend YieldDiv. Yield
1.28%
Sector PESector PE
35.85
Sector PBSector PB
4.38
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments

Financial TrendFinancial statements 

20192020202120220.001.421.031.130.000.250.180.19
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Re-appointment 
Announced OnNov 24, 2022

We are pleased to informed that the Shareholders of the Company have at their Annual General Meeting held on November 23, 2022, approved re-appointment of M/s. Haribhakti & Co. LLP, Chartered Accountants, as the Statutory Auditors for a second term of 5 (five) years ie. to hold office from the conclusion of this 55th Annual General Meeting upto the conclusion of 60th Annual General Meeting of the Company. | Download

We are pleased to informed that the Shareholders of the Company have at their Annual General Meeting held on November 23, 2022, approved re-appointment of M/s. Haribhakti & Co. LLP, Chartered Accountants, as the Statutory Auditors for a second term of 5 (five) years ie. to hold office from the conclusion of this 55th Annual General Meeting upto the conclusion of 60th Annual General Meeting of the Company. | Download

Annual General Meeting 
Announced OnNov 24, 2022

We would like to inform you that the 55th Annual General Meeting of the Company was held on November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed below:1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and2. Scrutinizer¬タルs ReportKindly take the above on record and oblige. | Download

We would like to inform you that the 55th Annual General Meeting of the Company was held on November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed below:1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and2. Scrutinizer¬タルs ReportKindly take the above on record and oblige. | Download

Cash Dividend 
Ex. DateNov 15, 2022

Final • Div/Share: ₹ 11.5

See all events